Concepedia

Kazimierz Wiśniewski

KW

Statistics

Publications

21

Citations

708

H-Index

16

Active since

1996

Affiliations

Ferring Pharmaceuticals (Switzerland)(Current)

University of Gdańsk

The University of Texas Medical Branch at Galveston

General Atomics (United States)

University of Manitoba

Kazimierz Wiśniewski is an author at Ferring Pharmaceuticals (Switzerland) specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

1996–2022

21

Publications

21

Novel d-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral κ-opioid receptors,

Todd W. Vanderah, Tally M. Largent‐Milnes, Josephine Lai et al. · European Journal of Pharmacology · 2008 · 100 citations

, , +14

The Selective Vasopressin Type 1a Receptor Agonist Selepressin (FE 202158) Blocks Vascular Leak in Ovine Severe Sepsis*

Marc O. Maybauer, Dirk M. Maybauer, Perenlei Enkhbaatar et al. · Critical Care Medicine · 2014 · 71 citations · Full text

Pharmacological Characterization of Apraglutide, a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist, for the Treatment of Short Bowel Syndrome

Diane M. Hargrove, Sudarkodi Alagarsamy, Glenn Croston et al. · Journal of Pharmacology and Experimental Therapeutics · 2020 · 56 citations · Full text

New, Potent, Selective, and Short-Acting Peptidic V<sub>1a</sub>Receptor Agonists

Kazimierz Wiśniewski, Robert Galyean, Hiroe Tariga et al. · Journal of Medicinal Chemistry · 2011 · 49 citations · Full text

Synthesis of achiral and chiral peptide nucleic acid (PNA) monomers using Mitsunobu reaction

Bogdan Falkiewicz, Aleksandra S. Kołodziejczyk, Bogdan Liberek et al. · Tetrahedron · 2001 · 48 citations

, , +7

1–5 of 21